Literature DB >> 2936423

Parkinson's disease in a Scottish city.

W J Mutch, I Dingwall-Fordyce, A W Downie, J G Paterson, S K Roy.   

Abstract

In a detailed community study the total prevalence of idiopathic Parkinson's disease in Aberdeen was 164.2/10(5) of the population. The age and sex specific prevalence rose to 2657.8/10(5) (2.7%) of men and 2071.0/10(5) (2.0%) of women aged over 84. The mean age at onset, irrespective of sex, was 65.3 years (SD 12.6) and varied little compared with similar studies over the past 25 years. Half of patients were independent but 78/225 (34.7%) were considerably disabled and 23/225 (10.2%) were confined to bed or a wheelchair. Disability increased with age and also with a low minimental state questionnaire score. The score was less than or equal to 7/10 (graded 0-10) in 93/252 (37%) of patients and less than 5/10 in 28/252 (11%). Parkinson's disease remains a common and disabling condition in the community.

Entities:  

Mesh:

Year:  1986        PMID: 2936423      PMCID: PMC1339516          DOI: 10.1136/bmj.292.6519.534

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN: 0267-0623


  14 in total

1.  ARTERIOSCLEROSIS IN PARKINSONISM.

Authors:  M J EADIE; J M SUTHERLAND
Journal:  J Neurol Neurosurg Psychiatry       Date:  1964-06       Impact factor: 10.154

2.  Dementia in Parkinson's disease.

Authors:  R J Marttila; U K Rinne
Journal:  Acta Neurol Scand       Date:  1976-11       Impact factor: 3.209

3.  Neurological disease in an English city.

Authors:  M Brewis; D C Poskanzer; C Rolland; H Miller
Journal:  Acta Neurol Scand       Date:  1966       Impact factor: 3.209

4.  Brief assessment of the mental state in geriatric domiciliary practice. The usefulness of the mental status questionnaire.

Authors:  L A Wilson; W Brass
Journal:  Age Ageing       Date:  1973-05       Impact factor: 10.668

5.  Epidemiologic studies of Parkinson's disease. II. A hospital-based survey.

Authors:  I I Kessler
Journal:  Am J Epidemiol       Date:  1972-04       Impact factor: 4.897

6.  Epidemiologic studies of Parkinson's disease. 3. A community-based survey.

Authors:  I I Kessler
Journal:  Am J Epidemiol       Date:  1972-10       Impact factor: 4.897

7.  The prevalence, natural history and dementia of Parkinson's disease.

Authors:  M Pollock; R W Hornabrook
Journal:  Brain       Date:  1966-09       Impact factor: 13.501

8.  Epidemiology of parkinsonism in Victoria.

Authors:  A C Jenkins
Journal:  Med J Aust       Date:  1966-09-10       Impact factor: 7.738

9.  The risk of Parkinson disease in Mediterranean people.

Authors:  G Rosati; E Granieri; L Pinna; I Aiello; R Tola; P De Bastiani; A Pirisi; M C Devoto
Journal:  Neurology       Date:  1980-03       Impact factor: 9.910

10.  Neurological disorders in the elderly at home.

Authors:  G A Broe; A J Akhtar; G R Andrews; F I Caird; A J Gilmore; W J McLennan
Journal:  J Neurol Neurosurg Psychiatry       Date:  1976-04       Impact factor: 10.154

View more
  43 in total

1.  Health related quality of life in Parkinson's disease: a prospective longitudinal study.

Authors:  K H Karlsen; E Tandberg; D Arsland; J P Larsen
Journal:  J Neurol Neurosurg Psychiatry       Date:  2000-11       Impact factor: 10.154

2.  Cross sectional prevalence survey of idiopathic Parkinson's disease and Parkinsonism in London.

Authors:  A Schrag; Y Ben-Shlomo; N P Quinn
Journal:  BMJ       Date:  2000-07-01

Review 3.  Health-related quality of life and healthcare utilisation in patients with Parkinson's disease: impact of motor fluctuations and dyskinesias.

Authors:  R C Dodel; K Berger; W H Oertel
Journal:  Pharmacoeconomics       Date:  2001       Impact factor: 4.981

Review 4.  Estrogenic modulation of brain activity: implications for schizophrenia and Parkinson's disease.

Authors:  Michel Cyr; Frederic Calon; Marc Morissette; Thérèse Di Paolo
Journal:  J Psychiatry Neurosci       Date:  2002-01       Impact factor: 6.186

5.  The economic impact of Parkinson's disease. An estimation based on a 3-month prospective analysis.

Authors:  R C Dodel; M Singer; R Köhne-Volland; T Szucs; B Rathay; E Scholz; W H Oertel
Journal:  Pharmacoeconomics       Date:  1998-09       Impact factor: 4.981

Review 6.  Modelling the cost effectiveness of treatments for Parkinson's disease: a methodological review.

Authors:  Judith Dams; Bernhard Bornschein; Jens Peter Reese; Annette Conrads-Frank; Wolfgang H Oertel; Uwe Siebert; Richard Dodel
Journal:  Pharmacoeconomics       Date:  2011-12       Impact factor: 4.981

7.  How valid is the clinical diagnosis of Parkinson's disease in the community?

Authors:  A Schrag; Y Ben-Shlomo; N Quinn
Journal:  J Neurol Neurosurg Psychiatry       Date:  2002-11       Impact factor: 10.154

8.  Parkinson's disease: disability, review, and management.

Authors:  W J Mutch; A Strudwick; S K Roy; A W Downie
Journal:  Br Med J (Clin Res Ed)       Date:  1986-09-13

9.  An exploration of ocular fixation in Parkinson's disease, multiple system atrophy and progressive supranuclear palsy.

Authors:  Ralph Allen Pinnock; Richard Canice McGivern; Raeburn Forbes; James Mark Gibson
Journal:  J Neurol       Date:  2009-10-22       Impact factor: 4.849

10.  Multidisciplinary rehabilitation for people with Parkinson's disease: a randomised controlled study.

Authors:  D T Wade; H Gage; C Owen; P Trend; C Grossmith; J Kaye
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-02       Impact factor: 10.154

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.